Published in Hypertension on April 01, 1996
The renin-angiotensin system and diabetes: an update. Vasc Health Risk Manag (2008) 1.30
The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am J Physiol Heart Circ Physiol (2012) 1.24
Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension (2009) 1.18
Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes (2011) 1.13
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest (1998) 1.00
Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism. Arch Physiol Biochem (2010) 0.98
The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise. Eur J Appl Physiol (2013) 0.86
Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act. Mol Cell Endocrinol (2012) 0.82
The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion. Clinics (Sao Paulo) (2013) 0.80
Sodium nitroprusside increases human skeletal muscle blood flow, but does not change flow distribution or glucose uptake. J Physiol (1999) 0.78
Candesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans. J Clin Endocrinol Metab (2012) 0.77
The Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Modifies Exercise-Induced Muscle Metabolism. PLoS One (2016) 0.77
The Impact of Different Plasma Glucose Levels on Heart Rate in Experimental Rats With Acute Myocardial Infarction. Cardiol Res (2016) 0.75
The AD8: a brief informant interview to detect dementia. Neurology (2005) 3.65
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature (2000) 2.87
Influence of body mass index on the response to asthma controller agents. Eur Respir J (2006) 2.41
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
Bilateral gracilis neosphincter construction for treatment of faecal incontinence. Br J Surg (1995) 2.07
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01
People at risk of schizophrenia. Sample characteristics of the first 100 cases in the Edinburgh High-Risk Study. Br J Psychiatry (1999) 1.98
Home blood pressure monitoring. Arch Intern Med (2000) 1.71
Brief screening tests versus clinical staging in senile dementia of the Alzheimer type. J Am Geriatr Soc (1990) 1.69
CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med (2000) 1.67
High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62
Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57
Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med (2000) 1.52
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51
Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49
Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48
Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes. Heart (2009) 1.47
Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44
Is karyotyping couples experiencing recurrent miscarriage worth the cost? BJOG (2010) 1.43
Reliability of clinical nurse specialists in the staging of dementia. Arch Neurol (1989) 1.41
Abdominal resection rectopexy with pelvic floor repair versus perineal rectosigmoidectomy and pelvic floor repair for full-thickness rectal prolapse. Br J Surg (1994) 1.36
Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol Med (1999) 1.34
Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28
Letter: Chromosome damage produced by psoralen and ultraviolet light. Br Med J (1976) 1.24
Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am J Neuroradiol (2009) 1.23
Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation (1971) 1.23
Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22
Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension (1997) 1.22
Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med (1977) 1.18
Research into fabrics used in compression therapy and assessment of their impact on treatment regimens. J Wound Care (2014) 1.16
Mutation induction in bacteria by freeze-drying. Cryobiology (1976) 1.16
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15
fMRI reveals distinct CNS processing during symptomatic and recovered complex regional pain syndrome in children. Brain (2008) 1.14
Transitory decrease in platelet monoamine-oxidase activity during migraine attacks. Lancet (1977) 1.11
Hemodynamic studies in patients with borderline blood pressure elevation. Circulation (1968) 1.11
Edinburgh high risk study--findings after four years: demographic, attainment and psychopathological issues. Schizophr Res (2000) 1.10
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation (1970) 1.10
Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation (1994) 1.10
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10
Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens (2013) 1.08
Easy money? Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class. Int J Clin Pract (2011) 1.07
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension (2000) 1.07
Drug information. Made to measure. Health Serv J (1994) 1.06
Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens (1997) 1.06
Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med (1972) 1.03
The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03
Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens (2000) 1.02
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest (1987) 1.02
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther (1977) 1.01
Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol (1975) 1.01
Borderline hypertension--a critical review. J Chronic Dis (1971) 1.00
Clinical evaluation of two strategies for improving patient recall of prior drug therapy. Br J Clin Pharmacol (1984) 1.00
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens (2001) 0.99
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99
Normal inferior vena cava: caliber changes observed by dynamic ultrasound. AJR Am J Roentgenol (1980) 0.97
Influence of hypertension on the hemodynamic response to exercise. Circulation (1967) 0.97
Conversion of psoralen DNA monoadducts in E. coli to interstrand DNA cross links by near UV light (320-360 nm): inability of angelicin to form cross links, in vivo. Experientia (1977) 0.95
Splenic abscess: comparison of four imaging methods. AJR Am J Roentgenol (1979) 0.93
Gonadotropin-releasing hormone action in the pituitary: a three step mechanism. Endocr Rev (1981) 0.93
Racial differences in erythrocyte cation transport. Hypertension (1984) 0.93
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood Press (1998) 0.92
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study. J Intern Med (2007) 0.92
Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines. N Engl J Med (1982) 0.92
Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure. The Tecumseh Blood Pressure Study. Hypertension (1992) 0.92
Genetic contribution to the variance in left ventricular mass: the Tecumseh Offspring Study. J Hypertens (2001) 0.91
Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension (1998) 0.91
Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens (1994) 0.90
Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension (1994) 0.90
Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Stat Med (1990) 0.89
Home blood pressure monitoring. Current knowledge and directions for future research. Blood Press (2001) 0.89
Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. Clin Sci Mol Med Suppl (1976) 0.89
Functions of the proteasome in antigen presentation. Cold Spring Harb Symp Quant Biol (1995) 0.89
Stroke volume--pulse pressure relationships in borderline hypertension: a possible indicator of decreased arterial compliance. J Hypertens Suppl (1984) 0.89
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study. J Hum Hypertens (2004) 0.89
Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension. Circ Res (1975) 0.88
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials. Blood Press (2001) 0.88
University of California, Davis, conference: Mild hypertension. Am J Med (1988) 0.87
Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther (1985) 0.87
Determinants of baroreflex sensitivity in man. J Lab Clin Med (1978) 0.87
Usefulness of home BP determination in treating borderline hypertension. JAMA (1982) 0.86
Abnormalities of plasma volume in borderline hypertension. Arch Intern Med (1971) 0.86
Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension (1983) 0.85
Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents. Hypertension (1984) 0.85
Effect of circulating epinephrine on platelet function and hematocrit. Hypertension (1995) 0.85
Evidence against an interaction of angiotensin II with the sympathetic nervous system in man. Clin Endocrinol (Oxf) (1981) 0.85
Sustained attention in young people at high risk for schizophrenia. Psychol Med (2002) 0.85
Syndrome X: is it for real? Genet Epidemiol (1998) 0.85
Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study. Am J Hypertens (1997) 0.85
Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol (1975) 0.85